Human YIPF2/FinGER2 ORF/cDNA clone-Lentivirus plasmid (NM_024029)

Cat. No.: pGMLP000445
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human YIPF2/FinGER2 Lentiviral expression plasmid for YIPF2 lentivirus packaging, YIPF2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.


Target products collection

Go to YIPF2/FinGER2 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $537.75
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP000445
Gene Name YIPF2
Accession Number NM_024029
Gene ID 78992
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 951 bp
Gene Alias FinGER2
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGCATCGGCCGACGAGCTGACCTTCCATGAATTCGAGGAGGCCACTAATCTTCTGGCTGACACCCCAGATGCAGCCACCACCAGCAGAAGCGATCAGCTGACCCCACAAGGGCACGTGGCTGTGGCCGTGGGCTCAGGTGGCAGCTATGGAGCCGAGGATGAGGTGGAGGAGGAGAGTGACAAGGCCGCGCTCCTGCAGGAGCAGCAGCAGCAGCAGCAGCCGGGATTCTGGACCTTCAGCTACTATCAGAGCTTCTTTGACGTGGACACCTCACAGGTCCTGGACCGGATCAAAGGCTCACTGCTGCCCCGGCCTGGCCACAACTTTGTGCGGCACCATCTGCGGAATCGGCCGGATCTGTATGGCCCCTTCTGGATCTGTGCCACGTTGGCCTTTGTCCTGGCCGTCACTGGCAACCTGACGCTGGTGCTGGCCCAGAGGAGGGACCCCTCCATCCACTACAGCCCCCAGTTCCACAAGGTGACCGTGGCAGGCATCAGCATCTACTGCTATGCGTGGCTGGTGCCCCTGGCCCTGTGGGGCTTCCTGCGGTGGCGCAAGGGTGTCCAGGAGCGCATGGGGCCCTACACCTTCCTGGAGACTGTGTGCATCTACGGCTACTCCCTCTTTGTCTTCATCCCCATGGTGGTCCTGTGGCTCATCCCTGTGCCTTGGCTGCAGTGGCTCTTTGGGGCGCTGGCCCTGGGCCTGTCAGCCGCCGGGCTGGTATTCACCCTCTGGCCCGTGGTCCGTGAGGACACCAGGCTGGTGGCCACAGTGCTGCTGTCCGTGGTCGTGCTGCTCCACGCCCTCCTGGCCATGGGCTGTAAGTTGTACTTCTTCCAGTCGCTGCCTCCGGAGAACGTGGCTCCTCCACCCCAAATCACATCTCTGCCCTCAAACATCGCGCTGTCCCCTACCTTGCCGCAGTCCCTGGCCCCCTCCTAG
ORF Protein Sequence MASADELTFHEFEEATNLLADTPDAATTSRSDQLTPQGHVAVAVGSGGSYGAEDEVEEESDKAALLQEQQQQQQPGFWTFSYYQSFFDVDTSQVLDRIKGSLLPRPGHNFVRHHLRNRPDLYGPFWICATLAFVLAVTGNLTLVLAQRRDPSIHYSPQFHKVTVAGISIYCYAWLVPLALWGFLRWRKGVQERMGPYTFLETVCIYGYSLFVFIPMVVLWLIPVPWLQWLFGALALGLSAAGLVFTLWPVVREDTRLVATVLLSVVVLLHALLAMGCKLYFFQSLPPENVAPPPQITSLPSNIALSPTLPQSLAPS

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-IP2288-Ab Anti-YIPF2 monoclonal antibody
    Target Antigen GM-Tg-g-IP2288-Ag YIPF2 protein
    ORF Viral Vector pGMLP000445 Human YIPF2 Lentivirus plasmid
    ORF Viral Vector vGMLP000445 Human YIPF2 Lentivirus particle


    Target information

    Target ID GM-IP2288
    Target Name YIPF2
    Gene ID 78992, 74766, 713753, 363027, 101101290, 484946, 515893, 100146288
    Gene Symbol and Synonyms 1300010K09Rik,FinGER2,RGD1307512,YIPF2
    Uniprot Accession Q9BWQ6
    Uniprot Entry Name YIPF2_HUMAN
    Protein Sub-location Introcelluar Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000130733
    Target Classification Not Available

    Predicted to enable small GTPase binding activity. Predicted to be involved in vesicle-mediated transport. Located in Golgi apparatus subcompartment and transport vesicle. [provided by Alliance of Genome Resources, Apr 2022]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.